Regeneron Pharmaceuticals (REGN) Inventory Average (2014 - 2026)

Regeneron Pharmaceuticals' Inventory Average history runs 13 years deep, the most recent figure standing at $3.2 billion for Q1 2026.

• In Q1 2026, Inventory Average changed 0.39% year-over-year to $3.2 billion; the TTM figure through Mar 2026 stood at $3.2 billion (changed 0.39% YoY), while the FY2025 annual figure was $3.1 billion, up 10.94% from the prior year.
• Inventory Average was $3.2 billion for Q1 2026 at Regeneron Pharmaceuticals, down from $3.2 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $3.2 billion in Q3 2025 to a low of $2.0 billion in Q1 2022.
• Historically, Inventory Average has averaged $2.7 billion across 5 years, with a median of $2.6 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average retreated 3.39% in 2022, then gained 22.42% in 2023.
• A 5-year view of Inventory Average shows it stood at $2.4 billion in 2022, then grew by 6.82% to $2.6 billion in 2023, then climbed by 18.72% to $3.1 billion in 2024, then advanced by 5.73% to $3.2 billion in 2025, then slipped by 2.34% to $3.2 billion in 2026.
• The last three Inventory Average figures came in at $3.2 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.2 billion (Q3 2025), per Business Quant data.